Genomes and Genes
MATRIX METALLOPROTEINASE AND APOPTOSIS IN BRAIN TRAUMA
Principal Investigator: ENG LO
Abstract: DESCRIPTION: (Verbatim from the Applicant's Abstract) In this proposal, we will use a mouse model of controlled cortical impact to test the idea that secondary cell death after traumatic brain injury is mediated by matrix metalloproteinases (MMP) which disrupt cell-matrix and cell-cell interactions, thus triggering apoptosis in brain regions beyond the site of original impact. Our working hypothesis states that: 1) mechanical stress induced by trauma activate MAP kinase signal transduction pathways, 2) MAP kinease pathways upregulate MMP expression, 3) MMP disrupts the extracellular matrix, and 4) disruption of cell-matrix and cell-cell interactions lead to apoptotic cell death. Preliminary data show that (a) the mouse model of controlled cortical impact is stable and reproducible in our lab; (b) western blots from traumatized brain show activation of the MAP kinase pathways ERK and SAPK2/p38; (c) the ERK/MAP kinase pathway upregulates MMP in vitro; (d) MMP activation occurs after trauma in vivo; (e) knockout mice deficient in MMP-9 show reduced injury after stroke and trauma, (f) direct injection of MMP-7 into mouse brain induces apoptosis; and (g) inhibition of the ERK/MAP kinase pathway reduces injury after stroke. We will extend our preliminary findings by pursuing the following specific aims. 1. Define the signaling pathways that lead to MMP upregulation and apoptosis after trauma. MMP gene promoter regions contain AP1 sites. Therefore, we propose that upstream activators of MMP involve MAP kinase signal transduction pathways. We will map the regional and temporal profiles of three major MAP kinsaes after trauma: ERK, SAPK1/JNK, and SAPK2/p38. Correlations between MAP kinase pathways, MMP expression , matrix disruption and apoptotic cell death will be assessed. 2. Characterize the role of specific MMP after trauma. We will examine morphological, biochemical and behavioral responses to trauma in MMP-2, MMP-7 and MMP-9 knockout mice, and transgenic mice overexpressing tissue inhibitor of MMP (TIMP-1). 3. Test the Neuroprotective effects of inhibitors of the ERK pathway (PD98059, U0216), p38 pathway (SB203580) and MMP (BB-94) for traumatic brain injury. Both morphological and behavioral outcomes will be measured. To date, there are not effective treatments for traumatic brain injury. Results from these proposed experiments will help identify MMP and upstream MAP kinase pathways as viable therapeutic targets for this devastating condition.
Funding Period: 2000-07-06 - 2005-06-30
more information: NIH RePORT
- Vascular endothelial growth factor regulates the migration of oligodendrocyte precursor cellsKazuhide Hayakawa
Neuroprotection Research Laboratory, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129, USA
J Neurosci 31:10666-70. 2011..Our findings demonstrate that VEGF-A can induce OPC migration via an ROS- and FAK-dependent mechanism, and suggest a novel role for VEGF-A in white-matter maintenance and homeostasis...
- Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) studyPeter J Kelly
Neurovascular Clinical Science Unit, Mater University Hospital and University College Dublin, Ireland
Stroke 39:100-4. 2008..We aimed to determine the change in plasma F2IP levels over time and relationship with plasma MMP-9 in tPA-treated and tPA-untreated stroke patients...
- Reduction of hippocampal cell death and proteolytic responses in tissue plasminogen activator knockout mice after transient global cerebral ischemiaS R Lee
Neuroprotection Research Laboratory, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02129, USA
Neuroscience 150:50-7. 2007..Taken together, these data suggest that endogenous tPA contributes to hippocampal injury after cerebral ischemia, and these pathophysiologic pathways may involve links to aberrant activation of caspases and MMPs...
- Cell-cell signaling in the neurovascular unitJosephine Lok
Neuroprotection Research Laboratory, Department of Radiology, Massachusetts General Hospital, MGH East 149 2401, Charlestown, MA 02129, USA
Neurochem Res 32:2032-45. 2007....
- TNF alpha and Fas mediate tissue damage and functional outcome after traumatic brain injury in miceDaniela Bermpohl
Neuroscience Center, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA
J Cereb Blood Flow Metab 27:1806-18. 2007....
- Neurovascular proteases in brain injury, hemorrhage and remodeling after strokeBing Qiao Zhao
Neuroprotection Research Laboratory, Department of Radiology, Massachusetts General Hospital, Charlestown, MA 02129, USA
Stroke 38:748-52. 2007..Acute versus chronic protease profiles within the neurovascular unit are likely to underlie critical responses to stroke, therapy, and recovery...
- Effects of apoE isoforms on beta-amyloid-induced matrix metalloproteinase-9 in rat astrocytesShuzhen Guo
Department of Neurology, Mass General Hospital, Charlestown, MA, USA
Brain Res 1111:222-6. 2006..Reduction of astrocytic MMP-9 by apoE4 may affect Abeta clearance and promote Abeta deposition in AD...
- Astrocytic induction of matrix metalloproteinase-9 and edema in brain hemorrhageEmiri Tejima
Neuroprotection Research Laboratory, Department of Radiology, Massachusetts General Hospital, and Program in Neuroscience, Harvard Medical School, Boston, MA, USA
J Cereb Blood Flow Metab 27:460-8. 2007....
- Association between tPA therapy and raised early matrix metalloproteinase-9 in acute strokeM Ning
Stroke Service, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
Neurology 66:1550-5. 2006..The authors investigated plasma MMP9 and its endogenous inhibitor, tissue inhibitor of metalloproteinase (TIMP1), in tPA-treated and -untreated stroke patients...
- Involvement of matrix metalloproteinase in neuroblast cell migration from the subventricular zone after strokeSeong Ryong Lee
Department of Neurology and Radiology, Massachusetts General Hospital, Boston, Massachusetts 02129, USA
J Neurosci 26:3491-5. 2006..These data suggest that MMPs are involved in endogenous mechanisms of neurogenic migration as the brain seeks to heal itself after injury...
- Role of matrix metalloproteinases in delayed cortical responses after strokeBing Qiao Zhao
Neuroprotection Research Laboratory, Department of Radiology, Massachusetts General Hospital, MGH East 149 2401, Charlestown, Massachusetts 02129, USA
Nat Med 12:441-5. 2006..These data suggest that, contrary to MMP inhibitor therapies for acute stroke, strategies that modulate MMPs may be needed for promoting stroke recovery...
- Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemiaKiyoshi Tsuji
Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA
Stroke 36:1954-9. 2005..Here, we used a combination of pharmacological and genetic approaches to show that tPA promotes MMP-9 levels in stroke in vivo...
- Crossing the blood-brain barrier: a potential application of myristoylated polyarginine for in vivo neuroimagingWellington Pham
MGH MIT HMS Athinoula A Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Charlestown, 02129, USA
Neuroimage 28:287-92. 2005..We conclude that this approach can be used for the delivery of imaging probes and potentially targeted therapeutics across the BBB...
- A pilot study of normobaric oxygen therapy in acute ischemic strokeAneesh B Singhal
Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Mass 02114, USA
Stroke 36:797-802. 2005..Therapies that transiently prevent ischemic neuronal death can potentially extend therapeutic time windows for stroke thrombolysis. We conducted a pilot study to investigate the effects of high-flow oxygen in acute ischemic stroke...
- Proteasome inhibition protects HT22 neuronal cells from oxidative glutamate toxicityKlaus van Leyen
Neuroprotection Research Laboratory, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA
J Neurochem 92:824-30. 2005..These findings suggest that caspases can be decoupled from oxidative stress under some conditions, and implicate the ubiquitin/proteasome pathway in neuronal cell death caused by oxidative glutamate toxicity...